@WelshBuffett
The only deal that I remember was from Gilead to Gritsone back in 2021.
under the terms Gilead paid Gritstone
- $30M in cash +30M in equity
- paid cost for HIV phase 1 clinical trial
- esclusive license to develop and commercialize it beyond phase 1
- 725M in regulatory and commercial milestone + royalties
- I am not sure if I missed anything else.
This was for phase 1. Imagine the possibilities for phase 3 HIV clinical trial for BIT.
We obviously don't know what's happening with Biotron and one day, hopefully soon, it will all be revealed.
@WelshBuffett The only deal that I remember was from Gilead to...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.002(3.70%) |
Mkt cap ! $50.52M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.2¢ | $51.10K | 945.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4281 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 625000 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.6¢ |
Change
0.002 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 5.2¢ | 5.6¢ | 5.2¢ | 183067 | ||
| Last updated 15.53pm 06/05/2024 ? | |||||
| BIT (ASX) Chart |